Complement in ANCA Vasculitis: Which Pathway Is Pivotal to the Patho…

Cleveland Clinic Department of Rheumatic and Immunologic Disease

A. Brown

Cleveland Clinic Rheumatic Case Studies: 32 y/o Male w/ Inflammatory…

Cleveland Clinic Department of Rheumatic and Immunologic Disease

L. Calabrese, J. Gelfand, C. Oddis, J. Cush, A. Kavanaugh, R. Hajj-Ali

Managing Dermatologic Conditions in Rheumatology: How to Differentia…

Cleveland Clinic Department of Rheumatic and Immunologic Disease

A. Fernandez

Neurosarcoidosis or CNS Vasculitis – Same or Different?

Cleveland Clinic Department of Rheumatic and Immunologic Disease

J. Gelfand

Managing Diagnosis Complications at Cleveland Clinic: How Should You…

Cleveland Clinic Department of Rheumatic and Immunologic Disease

C. Calabrese, C. Isada, L. Calabrese

CNS Vasculitis: Diagnostic Update

Cleveland Clinic Department of Rheumatic and Immunologic Disease

L. Calabrese

GPA and MPA: Is There Still a Role for Conventional Therapy?

Cleveland Clinic Department of Rheumatic and Immunologic Disease

Giant Cell Arteritis: How do I Take Care of My Patients?

Cleveland Clinic Department of Rheumatic and Immunologic Disease

K. Warrington

GPA and MPA: Is There Still a Role for Conventional Therapy? - Part 2

Cleveland Clinic Department of Rheumatic and Immunologic Disease

C. Langford

EGPA: Look Carefully at the Heart

Cleveland Clinic Department of Rheumatic and Immunologic Disease

W. Tang

Could EGPA be Treated with Biologics?

Cleveland Clinic Department of Allergy & Immunology

M. Wechsler

EGPA: Challenges and Prognosis

Cleveland Clinic Department of Rheumatic and Immunologic Disease

R. Hajj-Ali

Immunomodulatory Drugs (IMIDs) Advances in Disease Pathogenesis

Cleveland Clinic Department of Rheumatic and Immunologic Disease

W. Rigby

Are 14-3-3 Proteins Important Antigens in Large Vessel Vasculitis?

Cleveland Clinic Department of Rheumatic and Immunologic Disease

L. Calabrese, G. Hoffman